Literature DB >> 10581409

Localization of GDNF/neurturin receptor (c-ret, GFRalpha-1 and alpha-2) mRNAs in postnatal rat brain: differential regional and temporal expression in hippocampus, cortex and cerebellum.

T C Burazin1, A L Gundlach.   

Abstract

Recent studies have identified a multi-component receptor system for the neurotrophic factor, glial cell line-derived neurotrophic factor (GDNF) and its homolog, neurturin (NTN), comprising the signaling tyrosine kinase, Ret and multiple GPI-linked binding proteins, GDNF family receptor alpha-1 and alpha-2 (GFRalpha-1 and GFRalpha-2). In the present study the localization of c-ret and GFRalpha-1 and GFRalpha-2 mRNAs was assessed in the developing rat brain from postnatal day 4 to 70 by in situ hybridization histochemistry, using specific [35S]-labeled oligonucleotides. GFRalpha-1 and GFRalpha-2 mRNAs were differentially distributed throughout the brain at all ages studied, particularly in cerebral cortex, hippocampus, substantia nigra and regions of the thalamus and hypothalamus - both distributions overlapping but different to that of c-ret mRNA. C-ret mRNA was abundant in areas such as the lateral habenula, reticular thalamic nucleus, substantia nigra pars compacta, cranial motor nuclei, and the Purkinje cell layer of the cerebellum. GFRalpha-1 mRNA was abundant in dorsal endopiriform nucleus, medial habenula, reticular thalamic nucleus, pyramidal and granule cell layers of the hippocampus, substantia nigra pars compacta and in cranial motor nuclei. GFRalpha-2 mRNA was highly expressed in many regions including olfactory bulb, lateral olfactory tract nucleus, neocortical layers IV and VI, septum, zona incerta, and arcuate and interpeduncular nuclei. GFRalpha-2 mRNA was detected in the pyramidal cell layers (CA3) of hippocampus at P4 and P7, but was no longer detectable at P14 and beyond, including P70 (adult). GFRalpha-2 mRNA was also detected in Purkinje cells throughout the cerebellum in young postnatal rats, but was enriched in the posterior lobes at P28 and P70. These localization studies support evidence of GDNF/NTN as target-derived and autocrine/paracrine trophic factors in developing brain pathways and earlier suggestions of unique and complex signaling mechanisms for these factors via a family of receptors. Strong expression of GFRalpha-1 and GFRalpha-2 mRNAs in adult brain suggests possible non-trophic functions of GDNF/NTN, as described for other neurotrophins, such as brain-derived neurotrophic factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581409     DOI: 10.1016/s0169-328x(99)00217-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  24 in total

Review 1.  Cellular strategies of estrogen-mediated neuroprotection during brain development.

Authors:  Malgorzata Kajta; Cordian Beyer
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.

Authors:  Wayne A Cass; Laura E Peters
Journal:  Neurochem Int       Date:  2010-07-06       Impact factor: 3.921

Review 3.  Trophic factors therapy in Parkinson's disease.

Authors:  Shilpa Ramaswamy; Katherine E Soderstrom; Jeffrey H Kordower
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

4.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

5.  α1ACT Is Essential for Survival and Early Cerebellar Programming in a Critical Neonatal Window.

Authors:  Xiaofei Du; Cenfu Wei; Daniel Parviz Hejazi Pastor; Eshaan R Rao; Yan Li; Giorgio Grasselli; Jack Godfrey; Ann C Palmenberg; Jorge Andrade; Christian Hansel; Christopher M Gomez
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

6.  Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.

Authors:  G R Morel; Y E Sosa; M J Bellini; N G Carri; S S Rodriguez; M C Bohn; R G Goya
Journal:  Neuroscience       Date:  2010-02-26       Impact factor: 3.590

7.  Distribution of glial cell line-derived neurotrophic factor receptor alpha-1 in the brain of adult zebrafish.

Authors:  Carla Lucini; Lucini Carla; Bruna Facello; Facello Bruna; Lucianna Maruccio; Maruccio Lucianna; Fernanda Langellotto; Langellotto Fernanda; Paolo Sordino; Sordino Paolo; Luciana Castaldo; Castaldo Luciana
Journal:  J Anat       Date:  2010-06-21       Impact factor: 2.610

8.  Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.

Authors:  A Hurtado-Lorenzo; E Millan; V Gonzalez-Nicolini; D Suwelack; M G Castro; P R Lowenstein
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

9.  Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor.

Authors:  Sebastien Carnicella; Ryoji Amamoto; Dorit Ron
Journal:  Alcohol       Date:  2009-02       Impact factor: 2.405

10.  Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.

Authors:  William M Pardridge; Ruben J Boado
Journal:  Pharm Res       Date:  2009-07-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.